Also, experts measure the survival statistics every 5 years. So the estimate may not show the results of better diagnosis or treatment available for less than 5 years. Talk with your doctor if you have any questions about this information. Learn more about understanding statistics. The next section in this guide is Medical Illustrations. It offers drawings of body parts often affected by AML. Use the menu to choose a different section to read in this guide.
Types of Cancer. For the 5-year period from to , there were 61, new cases of MPNs throughout the United States US , averaging 12, cases per year. An estimated combined total of , people in the US are expected to be diagnosed with leukemia, lymphoma or myeloma in New cases of leukemia, lymphoma and myeloma are expected to account for 9.
Prevalence Prevalence is the estimated number of people alive on a certain date in a population who previously had a diagnosis of the disease. An estimated 1,, people in the United States US are living with or in remission from leukemia, lymphoma, myeloma, myelodysplastic syndromes MDS or myeloproliferative neoplasms MPNs.
Survival Relative survival compares the survival rate of a person diagnosed with a disease to that of a person without the disease. The most recent survival data available may not fully represent the outcomes of all current therapies and, as a result, may underestimate survival to a small degree.
Deaths Approximately every 9 minutes, someone in the US dies from a blood cancer. While there is currently no cure for leukemia, it is possible to treat the cancer to prevent it coming back. Treatment can last several months or even years depending on the type and severity of the condition. Receiving a leukemia diagnosis is life-changing and challenging for both an individual and their loved ones. It is common to feel a mixture of emotions after a cancer diagnosis, but everybody reacts differently in these situations.
Some may try to put on a brave face to protect their loved ones, while others will openly seek support. It is essential to remember that support is available for everyone from a wide range of sources, including:.
A doctor : Asking questions about leukemia, its symptoms, treatment options, stages, and survival rates can help a person understand their condition. Friends and family : Friends and family can provide intimate and emotional support. They can also help a person with everyday tasks that may become too difficult due to leukemia symptoms or treatment.
Support groups : These groups are helpful for meeting other people who can offer advice and support from their own lived experience or expertise. Support groups exist for both people with leukemia and their loved ones. Charities : Organizations, such as the Leukemia and Lymphoma Society , are dedicated to providing support to people with a cancer diagnosis.
Myelodysplastic syndromes MDS are a group of diseases that are often referred to a bone marrow failure disorders. In MDS, immature blood cells referred to as blasts are abnormal and build up in the bone marrow and the blood. Because of the proliferation of abnormal, immature cells, there are fewer healthy, functioning red and white blood cells and platelets. Treatment options for myelodysplastic syndromes include chemotherapy, immunotherapy, stem cell or bone marrow transplantation, and supportive care treatment to relieve symptoms and improve quality of life.
Treatment will depend upon the type and stage of myelodysplastic syndrome. New types of treatments are being developed and tested in clinical trials.
Myeloproliferative neoplasms MPN are types of blood cancer that begin with an abnormal mutation change in a stem cell in the bone marrow. The change leads to an overproduction of any combination of white cells, red cells and platelets. This group of blood disorders includes polycythemia vera, essential primary thrombocythemia and myelofibrosis.
Treatment options include:. If not treated, it can lead to serious bleeding or the formation of blood clots thrombosis. Some people with ET may not require treatment but others may need to take low-dose aspirin, hydroxyurea, anagrelide, or interferon. Novel new treatments are currently being developed and tested as a result of breakthroughs on the genetics of the disease.
In MF, there is excessive scar tissue in the bone marrow, which impairs the ability of the marrow to produce blood cells. This can result in a number of blood-associated disorders and problems. Treatment depends upon the type of blood cells that are affected by the disease. Facts and Statistics.
0コメント